Catalent today announced that it has been recognized by the Royal Society for the Prevention of Accidents (RoSPA) for its health and safety practices, achieving a silver award.
SOMERSET, N.J. – May 7, 2019 — Catalent, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it has been recognized by the Royal Society for the Prevention of Accidents (RoSPA) for its health and safety practices, achieving a silver award.
The RoSPA awards scheme, which is the longest-running industry awards scheme in the U.K., recognizes achievement in health and safety management systems, including practices such as leadership and workforce involvement.
Julia Small, Head of Qualifications, Awards and Events, RoSPA said, “The RoSPA Awards have become the key fixture in the health and safety calendar, with new sponsors and new awards this year including the Leisure Safety Awards, the Safe@Work Safe@Home Award and the Inspiration Awards. Highly-respected, with almost 2,000 entrants every year, RoSPA award winners benefit from the wide-ranging rewards of improved sector reputation.”
“This is a big achievement for the Catalent team, who strive to continuously improve our Environment, Health and Safety Management System,” commented Pete Williams, Vice-President, Global EHS, Security and Reliability Excellence at Catalent. He added, “This award reflects Catalent’s commitment to the environment and the health and safety of its employees, and the engagement of our employees in helping us to make Catalent a safer place to work.”
Catalent will be presented with the award during a ceremony on Tuesday, June 18, at the ExCel Exhibition Centre, London.
For more information about the RoSPA Awards visit www.rospa.com/awards.
Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With more than 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs over 11,000 people, including over 1,800 scientists, at more than 30 facilities across five continents, and in fiscal year 2018 generated approximately $2.5 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit www.catalent.com.